Analyze Diet

Topic:Drug

The topic of drugs and horses encompasses the study of various pharmacological agents used in equine medicine for therapeutic purposes. This includes the administration of medications for pain management, disease treatment, and performance enhancement. The pharmacokinetics and pharmacodynamics of drugs in horses are key areas of research, as they determine the absorption, distribution, metabolism, and excretion of these substances. Additionally, the topic covers the detection and regulation of substances in competitive equestrian sports to ensure fair play and animal welfare. This page compiles peer-reviewed research studies and scholarly articles that explore the effects, safety, and regulatory aspects of drug use in equine health and performance.
The pharmacokinetics of ivermectin after oral and subcutaneous administration to sheep and horses.
Journal of veterinary pharmacology and therapeutics    June 1, 1987   Volume 10, Issue 2 175-179 doi: 10.1111/j.1365-2885.1987.tb00097.x
Marriner SE, McKinnon I, Bogan JA.No abstract available
Pharmacokinetics and serum concentrations of cephapirin in neonatal foals.
American journal of veterinary research    May 1, 1987   Volume 48, Issue 5 805-806 
Brown MP, Gronwall R, Gossman TB, Houston AE.Six healthy foals, from 4 to 6 days of age, were given a single IM injection of sodium cephapirin (250 mg/ml) at a rate of 20 mg/kg of body weight. Serum concentrations of cephapirin were measured serially over an 8-hour period. The mean peak serum concentration was 21.2 micrograms/ml at 10 minutes. The overall elimination rate constant was 1.06/hr and the elimination half-life was 0.70 hour. The apparent volume of distribution at steady state was 1.06 L/kg and plasma clearance was 1,105 ml/hr/kg.
Pharmacokinetics of phenobarbital in the horse.
American journal of veterinary research    May 1, 1987   Volume 48, Issue 5 807-810 
Duran SH, Ravis WR, Pedersoli WM, Schumacher J.Pharmacokinetics of phenobarbital was examined in 6 mature horses after 12 mg of phenobarbital/kg of body weight was infused over 20 minutes. Biexponential decrease in serum phenobarbital concentrations was observed with a distribution-phase half-life of 0.101 +/- 0.086 hour (mean +/- SD) and a terminal-phase elimination half-life of 18.3 +/- 3.65 hours. The volume of distribution at steady state was 0.803 +/- 0.070 L/kg. Total body clearance of phenobarbital was 30.8 +/- 6.2 ml/h/kg. The high clearance in the horse seems to explain the markedly shorter half-life of phenobarbital in this speci...
Effects of multiple low doses of flunixin meglumine on repeated endotoxin challenge in the horse.
Prostaglandins, leukotrienes, and medicine    May 1, 1987   Volume 27, Issue 2-3 169-181 doi: 10.1016/0262-1746(87)90069-2
Semrad SD, Moore JN.Previous work has shown repeated low doses of flunixin meglumine (FM) inhibit thromboxane production in normal horses. Enhanced concentrations of thromboxane in serum occurred after the drug therapy was discontinued. Our study was performed to evaluate the effects of low doses of FM in horses repeatedly challenged with endotoxin. Group I horses received E. coli endotoxin (0.1 microgram/kg IV) at 0 and 90 h. Group II horses received endotoxin and were also treated with FM (0.25 mg/kg IV) at 2, 10, 18, 26, 34, and 42 h after the initial administration of endotoxin. Clinical signs of endotoxemia ...
Development of an enzyme-linked immunosorbent assay for the detection of phenothiazine tranquillisers in horses.
Research in veterinary science    May 1, 1987   Volume 42, Issue 3 415-417 
Smith ML, Chapman CB.An acepromazine (ACP) hapten was synthesised, coupled to bovine serum albumin and injected into a horse to produce antibodies to the drug. A competitive ELISA was developed whereby ACP attached to the solid phase via lysozyme competed with free ACP present in phosphate buffered saline, horse serum or horse urine for limiting amounts of antibody. The assay could detect the presence of ACP and, or, some of its metabolites in horse urine for at least 25 hours after intravenous injection of 0.1 mg kg-1 ACP maleate, but because of non-specific interference, horse serum could not be used. As little ...
Screening of amphetamines by gradient microbore liquid chromatography and pre-column technology.
Journal of chromatography    April 22, 1987   Volume 393, Issue 1 57-68 doi: 10.1016/s0021-9673(01)94204-9
Slais K, Nielen MW, Brinkman UA, Frei RW.Amphetamine-type drugs with a wide polarity range have been screened in both human and horse urine using on-line pre-concentration on pre-columns packed with hydrophobic and cation-exchange sorbents in series and gradient microbore high-performance liquid chromatography. The underivatized amphetamines were identified by UV detection at 210 nm. The method has potential for the automated liquid chromatographic screening of amphetamines in urine, e.g., for doping control.
Principles of drug disposition in the horse.
The Veterinary clinics of North America. Equine practice    April 1, 1987   Volume 3, Issue 1 221-250 doi: 10.1016/s0749-0739(17)30699-5
Sams RA.This article is intended to give the reader an understanding of the mathematic and conceptual framework underlying equine pharmacology. The methods by which the veterinary practitioner determines drug concentrations, disposition, and bioavailability are discussed.
Clinical pharmacology of the gastrointestinal tract.
The Veterinary clinics of North America. Equine practice    April 1, 1987   Volume 3, Issue 1 101-122 doi: 10.1016/s0749-0739(17)30693-4
Clark ES, Becht JL.This article discusses the various drugs that affect the equine gastrointestinal tract. Drugs that alter intestinal motility, that protect the gastrointestinal tract, and that alter secretions, as well as analgesics, appetite stimulants, and orally administered antimicrobial agents are reviewed.
Cardiovascular drugs. Their pharmacology and use in horses.
The Veterinary clinics of North America. Equine practice    April 1, 1987   Volume 3, Issue 1 37-57 doi: 10.1016/s0749-0739(17)30690-9
Muir WW, McGuirk S.Knowledge of the dosage, rate and route of administration, and potential side effects of drugs used to treat cardiac disease in horses has been refined. The judicious use of these drugs can increase exercise capacity, improve health, and potentially prolong life. Currently, antiarrhythmics (quinidine, lidocaine), positive inotropies (digoxin), and diuretics (furosemide) are the primary agents used to treat cardiovascular disease in horses. The development of newer drugs (verapamil, milrinone, bumetanide) and their usefulness in therapy for horses with cardiovascular disease require further inv...
Rational selection of antimicrobial drugs for treatment of infections of horses.
The Veterinary clinics of North America. Equine practice    April 1, 1987   Volume 3, Issue 1 191-220 doi: 10.1016/s0749-0739(17)30698-3
Brumbaugh GW.The goal of antimicrobial drug use is quite specific. Consideration of many microbe-related, host-related, and drug-related factors is necessary for appropriate selection and use of antimicrobial drugs in equine patients. The concepts and data presented in this article demonstrate that fact. At the risk of oversimplification, "The bug denotes the drug, and the horse directs the course."
Adverse drug reactions in the horse.
The Veterinary clinics of North America. Equine practice    April 1, 1987   Volume 3, Issue 1 153-179 doi: 10.1016/s0749-0739(17)30696-x
Davis LE.Adverse drug reactions occasionally occur in the horse. The majority can be anticipated and avoided. The practicing veterinarian should understand the various types of adverse reactions as well as their mechanisms so that should such a reaction occur, the practitioner can promptly recognize the problem and institute corrective measures.
Antimicrobic susceptibility of bacterial pathogens from horses.
The Veterinary clinics of North America. Equine practice    April 1, 1987   Volume 3, Issue 1 181-190 doi: 10.1016/s0749-0739(17)30697-1
Hirsh DC, Jang SS.Rational choice of an antimicrobial agent requires that the condition for which the drug is prescribed contain an infectious agent and, if so, knowledge of the susceptibility of the microorganism to antimicrobial drugs. Unfortunately, most infectious conditions necessitate the use of an antimicrobic drug before data from the microbiology laboratory are available. The data presented are meant to serve as a guide in the choice of antimicrobic drugs for treatment of infectious processes of the horse before knowledge of the nature of the microorganism isolated as well as its susceptibility to anti...
The bioavailability of phenylbutazone in the horse.
Xenobiotica; the fate of foreign compounds in biological systems    April 1, 1987   Volume 17, Issue 4 435-443 doi: 10.3109/00498258709043950
Smith PB, Caldwell J, Smith RL, Horner MW, Moss MS.[phenyl-14C]-Phenylbutazone was administered to 2 horses p.o. and i.v. on separate occasions. Plasma levels and urinary and faecal elimination of 14C were monitored for up to 7 days after dosing. Phenylbutazone was rapidly and extensively absorbed after oral administration, and its bioavailability was 91% assessed by comparison of plasma AUCs of unchanged drug after p.o. and i.v. administration. The plasma elimination half-life of phenylbutazone was 9.7 h and this was independent of the route of administration. The pattern of elimination of phenylbutazone was independent of the route of admini...
Pharmacologic considerations in drug therapy in foals.
The Veterinary clinics of North America. Equine practice    April 1, 1987   Volume 3, Issue 1 123-144 doi: 10.1016/s0749-0739(17)30694-6
Caprile KA, Short CR.Rational drug therapy in the foal requires a sound knowledge of the pharmacodynamics and pharmacokinetics of various drugs as well as a thorough understanding of the physiologic differences that exist between the neonate and the adult and that may serve to alter drug disposition and, therefore, drug response. A summary of these physiologic factors with emphasis on the foal is presented and is followed by recommendations regarding the applied therapeutics of various antimicrobial agents.
Drug therapy of respiratory disorders.
The Veterinary clinics of North America. Equine practice    April 1, 1987   Volume 3, Issue 1 59-80 doi: 10.1016/s0749-0739(17)30691-0
Beech J.The emphasis of this article is on the clinical application of drugs in therapy for treatment of disorders of the lower respiratory tract. Medications discussed include those used to enhance clearance of secretions and those employed to prevent and/or alleviate bronchoconstriction. Antimicrobial agents and respiratory stimulants are briefly mentioned.
Anthelmintics used in treatment of parasitic infections of horses.
The Veterinary clinics of North America. Equine practice    April 1, 1987   Volume 3, Issue 1 1-14 doi: 10.1016/s0749-0739(17)30688-0
DiPietro JA, Todd KS.The common anthelmintics used to treat parasitic infections of horses are described. Dosage, anthelmintic spectrum, formulation and administration, mode of action, toxicity contraindications, and resistance of parasites to anthelmintics are included.
Effect of yohimbine on xylazine-induced hypoinsulinemia and hyperglycemia in mares.
American journal of veterinary research    April 1, 1987   Volume 48, Issue 4 676-678 
Greene SA, Thurmon JC, Tranquilli WJ, Benson GJ.Serum insulin and plasma glucose concentrations were determined in 8 mares. Four IV treatments were studied: xylazine (1.1 mg/kg of body weight); yohimbine (0.125 mg/kg); yohimbine (0.125 mg/kg) followed 5 minutes later by xylazine (1.1 mg/kg); and 5 ml of isotonic saline solution as a control. Blood samples were collected before (time 0) and at 5, 15, 30, 60, 120, and 180 minutes after drug administration. Serum insulin concentration decreased and plasma glucose concentration increased in mares given xylazine. Plasma glucose concentration was unchanged in control mares and in mares given yohi...
Efficacy of four anthelmintics against benzimidazole-resistant cyathostomes of horses.
The Veterinary record    March 28, 1987   Volume 120, Issue 13 293-296 doi: 10.1136/vr.120.13.293
Bürger HJ, Bauer C.In order to confirm benzimidazole resistance as recommended at a workshop of the Commission of the European Communities the isolate 'E' of cyathostome strongyles originating from a stud where benzimidazole resistance had been demonstrated by egg hatch tests and by egg count reduction tests was investigated in two series of critical tests. Each of 11 foals reared strongyle-free was infected with 130,000 third stage cyathostome larvae. One animal remained untreated, two pairs of foals were treated with paste formulations of the (pro)benzimidazoles cambendazole (20 mg/kg bodyweight) or febantel (...
Determination of climazolam in the plasma of farm animals by gas chromatography.
Journal of chromatography    March 20, 1987   Volume 415, Issue 1 170-176 doi: 10.1016/s0378-4347(00)83206-5
Heizmann P, Jordan JC, Ludwig B.No abstract available
Plasma concentration of gentamicin after intramuscular or subcutaneous administration to horses.
Journal of veterinary pharmacology and therapeutics    March 1, 1987   Volume 10, Issue 1 101-103 doi: 10.1111/j.1365-2885.1987.tb00084.x
Gilman JM, Davis LE, Neff-Davis CA, Koritz GD, Baker GJ.No abstract available
Detection and identification of ketamine and its metabolites in horse urine.
Journal of analytical toxicology    March 1, 1987   Volume 11, Issue 2 58-62 doi: 10.1093/jat/11.2.58
Sams R, Pizzo P.The possibility exists that ketamine, or ketamine in combination with xylazine, is being used illicitly to affect the performance of racehorses. This study was undertaken to identify the metabolites of ketamine in the urine of adult horses and to evaluate methods for detecting and confirming ketamine administration. Detection of ketamine and two ketamine metabolites is described using thin-layer chromatography (TLC) and their identities are confirmed by comparing their mass spectra and gas chromatographic retention times with those of authentic standards.
Pharmacokinetics and renal clearance of sulfamethazine, sulfamerazine, and sulfadiazine and their N4-acetyl and hydroxy metabolites in horses.
American journal of veterinary research    March 1, 1987   Volume 48, Issue 3 392-402 
Nouws JF, Firth EC, Vree TB, Baakman M.Plasma disposition, protein binding, urinary recovery, and renal clearance of sulfamethazine (SMZ), sulfamerazine (SMR), and sulfadiazine (SDZ) and their N4-acetyl and hydroxy derivatives were studied in 4 horses in a crossover trial. The plasma concentration-time curves of the metabolites paralleled those of the parent drug in the elimination phase. Sulfamethazine and SMR were extensively metabolized. In plasma and urine, the main metabolite of the 3 sulfonamides tested was the 5-hydroxypyrimidine derivative, which was highly glucuronidated. Difference in elimination half-life of SMZ, SMR, an...
Antimicrobial selection and dosage in the treatment of equine bacterial infections.
Equine veterinary journal    March 1, 1987   Volume 19, Issue 2 92-96 doi: 10.1111/j.2042-3306.1987.tb02596.x
Baggot JD, Prescott JF.The success of antimicrobial therapy depends on administration of an agent to which the pathogenic microorganisms are susceptible at the concentrations attained at the site of infection. The route of administration, size of the dose and dosing interval must be appropriate for the drug preparation selected. With penicillins in particular, dosage can be tailored to the severity of the infection and quantitative susceptibility of the microorganism. This approach cannot be applied to aminoglycosides because their relatively narrow margin of safety limits the amount which can be administered. In se...
Single- and repeat-dose pharmacokinetic studies of chloramphenicol in horses: values and limitations of pharmacokinetic studies in predicting dosage regimens.
American journal of veterinary research    March 1, 1987   Volume 48, Issue 3 403-406 
Varma KJ, Powers TE, Powers JD.A single-dose pharmacokinetic study of chloramphenicol in propylene glycol was done in 6 horses after 22 mg/kg was administered IV. Serum drug concentrations obtained at various predetermined intervals were determined by an electroncapture gas-chromatographic technique. The time-concentration data were described by a 2-compartment open model, and various pharmacokinetic variables were estimated. The median elimination rate constant was estimated to be -0.0185 minute-1 (-0.0225 to -0.0148 minute-1), and the median half-life was 37.36 minutes (30.74 to 46.90 minutes). The median apparent volume ...
Inactivation of horse liver mitochondrial aldehyde dehydrogenase by disulfiram. Evidence that disulfiram is not an active-site-directed reagent.
The Biochemical journal    March 1, 1987   Volume 242, Issue 2 499-503 doi: 10.1042/bj2420499
Sanny CG, Weiner H.The inhibition of mitochondrial (pI 5) horse liver aldehyde dehydrogenase by disulfiram (tetraethylthiuram disulphide) was investigated to determine if the drug was an active-site-directed inhibitor. Stoichiometry of inhibition was determined by using an analogue, [35S]tetramethylthiuram disulphide. A 50% loss of the dehydrogenase activity was observed when only one site per tetrameric enzyme was modified, and complete inactivation was not obtained even after seven sites per tetramer were modified. Modification of only two sites accounted for a loss of 75% of the initial catalytic activity. Th...
Effects of xylazine on equine intestinal vascular resistance, motility, compliance, and oxygen consumption.
American journal of veterinary research    February 1, 1987   Volume 48, Issue 2 198-203 
Stick JA, Chou CC, Derksen FJ, Arden WA.Isolated jejunal segments were perfused at a constant blood flow rate to determine simultaneously the effects of xylazine on intestinal vascular resistance, motility, compliance, and oxygen consumption in 12 anesthetized ponies. Xylazine was infused into the artery perfusing the intestinal segment (group 1), or into the jugular vein as a single IV bolus (group 2), or 3 times as IV boluses repeated at 10-minute intervals (group 3). Dose-response curves in group 1 indicated a biphasic response to the drug with vasoconstriction, increased motility, and increased oxygen consumption at lower doses ...
Unexpected responses following intravenous pethidine injection in two horses.
Equine veterinary journal    January 1, 1987   Volume 19, Issue 1 72-73 doi: 10.1111/j.2042-3306.1987.tb02587.x
Clutton RE.No abstract available
Antipyrine and lidocaine are cleared faster in horses than in humans: acetaminophen may be handled similarly.
Pharmacology    January 1, 1987   Volume 34, Issue 4 192-200 doi: 10.1159/000138269
Engelking LR, Lofstedt J, Blyden GT, Greenblatt DJ.The following studies were designed to evaluate plasma elimination kinetics of intravenously administered antipyrine, acetaminophen and lidocaine among 9 healthy adult horses and 9 healthy drug-free humans (3 each per drug group), in order to compare potential species differences in drug-metabolizing ability. Acetaminophen is largely biotransformed in humans by hepatic glucuronide and sulfate conjugation, whereas both antipyrine and lidocaine are oxidized by hepatic microsomal mixed-function oxidases. Thus, plasma clearances of these drugs are thought to reflect differences in hepatic oxidativ...
Use of a novel non-steroidal anti-inflammatory drug in the horse.
Equine veterinary journal    January 1, 1987   Volume 19, Issue 1 60-66 doi: 10.1111/j.2042-3306.1987.tb02584.x
Higgins AJ, Lees P, Sedgwick AD, Buick AR, Churchus R.In a two-part cross-over experiment in six ponies, an acute inflammatory reaction was generated by injecting carrageenin solution into subcutaneously-implanted tissue-cages lined with fibrovascular granulation tissue. In each part of the cross-over, half of the ponies received a novel phenylpyrazoline anti-inflammatory agent (BW540C) orally and half received a placebo treatment. BW540C inhibited platelet cyclo-oxygenase for 24 h but the reductions in exudate eicosanoid concentrations were less pronounced. A significant suppression in the rise of surface skin temperature in BW540C-treated ponie...
[The clinical pharmacology of glycerol guaiacolate ether in the horse–a review].
Journal of the South African Veterinary Association    December 1, 1986   Volume 57, Issue 4 247-249 
Stadler P.The physical and chemical properties, administration, biotransformation, pharmacological effects, clinical applications, side-effects, toxicity and contraindications of glyceryl guaiacolate ether in the horse are reviewed.
1 77 78 79 80 81 94